CEO Turtle Cameron sold 15,000 shares at $87.69 for $1.3M, trimming directly held shares by 2.5% (from 597,540 to 582,540), with the transaction price sitting 14.0% below the 90-day high of $102.06. Seven straight monthly sales totaling over $5.5M, combined with Fairmount Funds' full $400M exit on June 24 and a director's $2M disposal, creates a notable insider distribution pattern heading into August 3 earnings with consensus EPS at -$0.77. Bull case: STRONG BUY consensus (22/23 analysts) holds and the stock reclaims $102; bear case: breaks $68.50 support, the 30-day low, which would confirm the distribution pattern.

Where it could go — Our 5-6 conviction officer sells: 52% beat SPY at 30d (n=1091); bull holds $87.69, bear breaks $68.50.

SYRE Chief Medical Officer Sloan Sheldon exercised options and sold 8,334 shares for $731K at $87.70, maintaining their existing stake percentage. This appears to be a routine option monetization rather than a bearish signal, especially given the STRONG BUY analyst consensus and no other insider selling activity.

Where it could go — Our 1-4 conviction officer sells: 59% beat SPY at 30d (n=2290, avg +3.3% vs SPY); analyst mean target implies potential upside from current levels.

CFO Burrows Scott sold $658K worth of newly exercised shares at $87.74, representing his 8th such transaction with no change to his core holdings. This is a mechanical monetization of expiring options, not a signal of reduced conviction, especially against a backdrop of 23 analyst Strong Buy ratings.

Where it could go — Our 1-4 conviction officer sells: 59% beat SPY at 30d; bear case if stock breaks the 90-day low of $46.26.

CFO Scott Burrows sold 15,000 newly exercised option shares at $87.13, generating $1.3M — his largest single exercise-and-sell to date, with the transaction price sitting 14.6% below the 90-day high of $102.06 and 94.5% above the 90-day low. This is a mechanical exercise-and-sell with no change to pre-existing holdings, continuing a pattern of monthly option monetizations ($102K in March, $370K in April, $892K in May, $533K in June 1) that signals scheduled compensation harvesting rather than a bearish directional view — though it lands one day after Fairmount Funds exited a $400M stake, adding broader distribution pressure. Bull case: stock holds above $68.50 (30-day low) into the August 3 earnings print with consensus EPS at -$0.77; bear case: breaks $68.50 and institutional selling accelerates.

Where it could go — Broad base rate 41.7% positive at 90d for this signal type; bull holds $68.50, bear breaks that level.

Director Fairmount Funds Management LLC sold their entire $400M direct stake at $85.31 per share, exiting their position completely after holding since at least 2020. This massive liquidation by a long-term holder near double the 90-day low price represents significant profit-taking despite the STRONG BUY analyst consensus.

Where it could go — 2 similar SYRE signals averaged +1.9% at 30d; watch $102.06 as resistance, $68.50 as support break level.

Director Michael Henderson sold $2M worth of SYRE shares at $100, reducing his directly held stake by 22.6% while the stock traded just 1.7% below its 90-day high. This second substantial sale in recent weeks suggests ongoing portfolio rebalancing rather than a fundamental concern, especially given the STRONG BUY analyst consensus.

Where it could go — 2 similar SYRE setups → +1.9% at 30d; watch $101.71 as breakout level, $68.50 as support break.

Burrows Scott L exercised 7,500 options at $14.50 and sold the resulting shares at $69.75 ($126K). The sale came from newly exercised options and did not reduce previously held shares, leaving 103,693 directly held shares.

Where it could go — Exercise-and-sell transactions are largely mechanical and carry limited directional signal.

Burrows Scott L exercised 7,500 options at $14.50 and sold the resulting shares at $69.75 ($126K). The sale came from newly exercised options and did not reduce previously held shares, leaving 103,693 directly held shares.

Where it could go — Exercise-and-sell transactions are largely mechanical and carry limited directional signal.

Burrows Scott L exercised 7,500 options at $14.50 and sold the resulting shares at $69.75 ($126K). The sale came from newly exercised options and did not reduce previously held shares, leaving 103,693 directly held shares.

Where it could go — Exercise-and-sell transactions are largely mechanical and carry limited directional signal.

CEO Turtle Cameron sold $247K worth of SYRE shares at $69.40, reducing their stake by 0.6% while the stock traded 11.9% below its 90-day high. This first-time sale by the CEO contradicts the STRONG BUY analyst consensus but lacks cluster support and historical precedent for significance.

Where it could go — Analyst mean target unavailable; bear case if stock breaks below $64.67 support.

Sloan Sheldon exercised 8,333 options at $27.46 and sold the resulting shares at $75.00 ($625K). The sale came from newly exercised options and did not reduce previously held shares.

Where it could go — Exercise-and-sell transactions are largely mechanical and carry limited directional signal.

Director Michael Thomas Henderson executed a Code-S transaction, selling 2,404 shares at $72.57 for $174K, reducing his stake by 1.4% from 168,606 to 166,202 shares. This is the first Form 4 filing for Henderson, with no prior Code-P or Code-S transactions on record. The sale occurred at a price near the 90d high of $76.00, with no upcoming earnings catalysts and a STRONG BUY consensus from 23 analysts.

Where it could go — In the absence of historical return data for similar SYRE signals, the bear case is supported by the timing of this first insider sale near the 90d high; bearish thesis strengthens if stock breaks below $32.35, the 90d low.

Director Michael Thomas Henderson executed a Code-S transaction, selling 2,404 shares at $72.57 for $174K, reducing his stake by 1.4% from 168,606 to 166,202 shares. This is the first Form 4 filing for Henderson, with no prior Code-P or Code-S transactions on record. The sale occurred at a price near the 90d high of $76.00, with no upcoming earnings catalysts and a STRONG BUY consensus from 23 analysts.

Where it could go — In the absence of historical return data for similar SYRE signals, the bear case is supported by the timing of this first insider sale near the 90d high; bearish thesis strengthens if stock breaks below $32.35, the 90d low.